Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. The gene discussed is G0S2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.